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Mutations in Cytokine Receptor-Like Factor 1 (CRLF1) Account
for Both Crisponi and Cold-Induced Sweating Syndromes
N. Dagoneau, S. Bellais, P. Blanchet, P. Sarda, L. I. Al-Gazali, M. Di Rocco, C. Huber, F. Djouadi,
C. Le Goff, A. Munnich, and V. Cormier-Daire
Crisponi syndrome is a rare autosomal recessive disorder characterized by congenital muscular contractions of facial
muscles, with trismus in response to stimuli, dysmorphic features, bilateral camptodactyly, major feeding and respiratory
difﬁculties, and access of hyperthermia leading to death in the ﬁrst months of life. The overlap with Stu¨ve-Wiedemann
syndrome (SWS) is striking, but the two conditions differ in that congenital lower limb bowing is absent in Crisponi
syndrome, whereas it is a cardinal feature of SWS. We report here the exclusion of the leukemia inhibitory factor receptor
gene in Crisponi syndrome and the identiﬁcation of homozygote or compound heterozygote cytokine receptor-like factor
1 (CRLF1) mutations in four children from three unrelated families. The four mutations were located in the immuno-
globulin-like and type III ﬁbronectin domains, and three of them predicted premature termination of translation. Using
real-time quantitative polymerase chain reaction, we found a signiﬁcant decrease in CRLF1 mRNA expression in patient
ﬁbroblasts, which is suggestive of a mutation-mediated decay of the abnormal transcript. CRLF1 forms a heterodimer
complex with cardiotrophin-like cytokine factor 1, and this heterodimer competes with ciliary neurotrophic factor for
binding to the ciliary neurotrophic factor receptor (CNTFR) complex. The identiﬁcation of CRLF1 mutations in Crisponi
syndrome supports the key role of the CNTFR pathway in the function of the autonomic nervous system.
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Crisponi syndrome (MIM 601378) is a rare autosomal re-
cessive disorder characterized by congenital contractions
of facial muscles, with trismus in response to stimuli or
during crying; dysmorphic features, including round face,
broad nose with anteverted nostrils, small mouth, and
micrognathia; and bilateral camptodactyly. Major feeding
and respiratory difﬁculties with access of hyperthermia
occur in the course of the disease and usually lead to death
in the ﬁrst months of life. In the rare survivors, hyper-
excitability disappears in the ﬁrst years of life, but children
develop scoliosis and psychomotor retardation.1–3 So far,
the disease has been reported in a total of 19 newborns
from Sardinian, Italian, and Portuguese families.
The overlap of Crisponi syndrome with Stu¨ve-Wiede-
mann syndrome (SWS, or Schwartz-Jampel syndrome type
2) is striking, since both conditions cause contractures at
birth, pursed appearance of the mouth, camptodactyly,
feeding and respiratory difﬁculties, hyperthermia, and pro-
gressive kyphoscoliosis.4,5 However, congenital bowing of
the lower limbs with internal cortical thickening and me-
taphyseal changes (which are cardinal features of SWS)
have never been reported in newborn patients with Cris-
poni syndrome.
A total of four children belonging to three unrelated
families were included in the study. The ﬁrst patient was
born to unrelated Sardinian parents (family 1), at 28 wk
of gestation by cesarean section (birth weight 980 g). She
presented at birth with facial muscle contractions, camp-
todactyly, and feeding difﬁculties, and she had major ac-
cess of hyperthermia during her 1st year of life. Muscle
biopsy and skeletal x-ray results were normal. Hyperex-
citability and hyperthermia episodes disappeared after age
1 year. She then developed scoliosis, requiring surgery at
age 12 years, andmild developmental delaywith attention
deﬁcit disorder, requiring special schooling. She is now
aged 13 years, and growth parameters are at !2 SD.
The second patient was born to Yemenite parents who
were ﬁrst cousins (family 2). She was ﬁrst given a diagnosis
of neonatal Schwartz-Jampel syndrome type 2, since she
presented suggestive dysmorphic features, pursed appear-
ance of the mouth during crying, bilateral camptodactyly,
poor suckling, and swallowing difﬁculties, but no bowing
of the lower limbs. The family was then lost to follow up.
Patients 3 and 4 were ﬁrst cousins born to related Gypsy
parents (family 3). Patient 3 presented at birth with camp-
todactyly, overlapping toes, joint contractures of elbows,
contractions of facial muscles with trismus, major feeding
difﬁculties, and dysmorphic features (i.e., small nose with
anteverted nostrils, small mouth, short neck, and low-set
ears). He had transient increase of plasma creatine kinases
but normal x-ray results. In the course of the disease, hy-
perexcitability disappeared and feeding difﬁculties im-
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Figure 1. A, Pedigrees and segregation of the CRLF1 mutations identiﬁed in the three families with Crisponi syndrome. B, Exon-intron
structure of the CRLF1 gene. Mutations are located in the region encoding the Ig and FNIII domains. wt p Wild type.
proved, but he presented iterative access of hyperthermia
(body temperature 142C) until age 3 years and then pro-
fuse sweating of the back. Kyphoscoliosis appeared at age
1 year. He is now aged 6 years (growth parameters at 2
SD) and has some speech delay. Results of brain magnetic
resonance imaging, heart ultrasound, chromosome anal-
ysis, and skeletal muscle biopsy were normal. Patient 4 is
the ﬁrst cousin of patient 3 (ﬁg. 1). He also presented at
birth with facial muscle contractions, camptodactyly, el-
bow contractures, and feeding difﬁculties, and he devel-
oped seizures and temperature instability with access of
hyperthermia and kyphoscoliosis.
Blood samples and skin ﬁbroblasts (from patients 1, 3,
and 4) were obtained with the written consent of the pa-
tients and relatives. For patient 1, samples from the par-
ents were not available.
We ﬁrst considered the leukemia inhibitory factor re-
ceptor gene (LIFR, or gp190 [GenBank accession number
NM_002310]), the gene responsible for SWS, as a possible
candidate gene. Binding of the leukemia inhibitory fac-
tor (LIF) to the LIFR complex (gp130-gp190 [GenBank ac-
cession number NP_002301]) is known to induce signaling
through the Janus kinase (JAK)/signal transducers and
activators of transcription (STAT) and mitogen-activated
protein kinase pathways (ﬁg. 2). The activation of STAT3
in response to LIF was therefore tested in patients with
Crisponi syndrome (patients 1, 3, and 4) and in a patient
with SWS carrying LIFR mutations. The cells were incu-
bated in a serum-free medium for 15 min with 20 ng/ml
LIF, as described elsewhere.5 Western-blot analysis of ﬁ-
broblast lysates with use of an antiphospho-STAT3 anti-
body showed that LIF normally triggered STAT3 phos-
phorylation in patients with Crisponi syndrome, whereas
STAT3 failed to be phosphorylated in response to LIF in
ﬁbroblasts from a patient with SWS (data not shown). For
patient 2, skin ﬁbroblasts were not available. A series of
42 intronic primers were therefore used to amplify the 20
coding exons of LIFR, and results from the direct sequenc-
ing of LIFR were normal.
On the basis of the recent identiﬁcation of cytokine
receptor-like factor 1 (CRLF1 [GenBank accession number
NM_004750]) mutations in three families with cold-
induced sweating syndrome (CISS [MIM #272430]),6,7 we
then considered CRLF1 as a possible candidate gene in
Crisponi syndrome. CRLF1 (GenBank accession number
NP_004741) forms a heterodimer complex with cardi-
otrophin-like cytokine factor 1 (CLCF1 [GenBank acces-
sion number NP_037378]), and this heterodimer com-
petes with ciliary neurotrophic factor (CNTF) for bind-
ing to the ciliary neurotrophic factor receptor (CNTFR
[GenBank accession number NP_671693]) complex,
which is composed of IL-6ST (gp130 [GenBank accession
number NP_786943]), LIFR (gp190), and CNTFR (ﬁg. 2).8
Binding of the heterodimer to the receptor activates the
JAK/STAT signaling pathway. The CRLF1 gene is com-
posed of nine exons and encodes a 422-aa protein com-
prising one immunoglobulin (Ig)–like domain and two
ﬁbronectin type III (FNIII) domains. A series of 18 primers
was designed to amplify the nine coding exons of CRLF1,
and a total of four distinct mutations were identiﬁed
in the three families: c.226TrG and c.676dupA (p.W76G
and p.Thr226AsnfsX104), c.5275GrA/c.5275GrA,
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Figure 2. Schematic representation of the LIFR and CNTFR path-
ways (from the work of Plun-Favreau et al.8). Binding of LIF to
the LIFR complex (gp130-gp190) and binding of CNTF or CRLF1-
CLCF1 to the CNTFR complex (CNTFR-gp130-gp190) activate the
JAK/STAT pathway.
Figure 3. RT-PCR detection of CRLF1 transcripts. RT-PCR analyses
were done using RNA isolated from control muscle, chondrocytes,
and brain from ﬁbroblasts of controls (C) and patients (1, 3, and
4). Thirty PCR cycles were performed at an annealing temperature
of 60C to amplify a 381-bp fragment speciﬁc to the CRLF1 gene
(forward primer 5′-AAGAACATGAAGGACTTGACCTG-3′; reverse primer
5′-GTATTTGGCTTGAAAGAGGAAATC-3′). Sense and antisense primers
used for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) am-
pliﬁcation were 5′-AGACAGCCGCATCTTCTTGT-3′ and 5′-CCACAGTCTTC-
TGAGTGGCA-3′ (product length 587 bp). The speciﬁc RNA transcript
was found in control tissues but was barely detectable in Crisponi
syndrome ﬁbroblasts.
and c.713dupC/c.713dupC (p.Asp240AlafsX91/
p.Asp240AlafsX91) (ﬁg. 1). The mutations were located in
the regions encoding the Ig-like domain and the two FNIII
domains of the protein, and three of them predicted pre-
mature termination of translation. The base changes were
not identiﬁed in 210 control chromosomes.
We then analyzed the pattern of expression of CRLF1
in tissues presumably involved in Crisponi syndrome. To-
tal RNA was extracted from human tissues or primary cul-
tured cells (i.e., muscle, chondrocytes, ﬁbroblasts, and
adult brain) with use of the RNeasy Mini Kit (Qiagen). RT-
PCR analysis of CRLF1 RNA transcripts detected a single
ampliﬁcation product in muscle, chondrocytes, ﬁbro-
blasts, and brain from controls. By contrast, RT-PCR anal-
ysis of the ﬁbroblast RNA transcripts detected only a weak
signal in patients 1, 3, and 4 (ﬁg. 3). We ﬁnally performed
a real-time quantitative PCR, using LightCycler technol-
ogy (Roche Manheim). RT-PCR was performed using the
following primers: forward 5′-TACCAGATCCGCTACCG-
AGTG-3′ and reverse 5′-GCTCCACTCACTCCAGATCC-3′
(product length 180 bp). The experiments were performed
two times. In each experiment, samples were run in trip-
licate. The amounts of CRLF1 mRNA were normalized to
the amount of b-actin mRNA measured in each sample.
The expression of CRLF1 mRNA appeared signiﬁcantly
lower in the three patients, with 13%–21% of control val-
ues (ﬁg. 4). These ﬁndings were highly suggestive of a
mutation-mediated decay of the abnormal transcript.
Mutations of both CRLF1 and CLCF1 (GenBank acces-
sion number NM_013246) have been recently identiﬁed
in CISS, which is characterized by profuse sweating in-
duced by cool temperatures, nasal voice, depressed nasal
bridge, inability to fully extend elbows, and kypho-
scoliosis.6,7,9 This entity is distinct from Crisponi syn-
drome, in that it has a later onset, a less severe outcome,
no facial muscle contractions or trismus, and no hyper-
thermia (body temperature 142C) in the neonatal period.
The reported patients with CISS ranged in age from 13
years to 46 years, whereas, among the 22 patients with
Crisponi syndrome, only 6 are still alive. The neonatal
features of Crisponi syndrome (i.e., hyperthermia, facial
contractures, trismus, and feeding difﬁculties) disappear
after the ﬁrst years of life, and the clinical course becomes
quite similar to that of CISS (i.e., ﬂexion deformities of
the ﬁngers, progressive kyphoscoliosis, and cold-induced
sweating). This last feature was observed in only one of
four patients from our series; however, another patient of
the four was lost to follow up, and the development of
paradoxical sweating in the course of the disease cannot
be excluded.
Whether Crisponi syndrome and CISS are allelic dis-
orders or parts of a single entity described at different
stages is questionable. Among the four mutations iden-
tiﬁed in Crisponi syndrome, three are splice-site and
frameshift mutations, whereas, among the ﬁve mutations
identiﬁed in CISS, three are missense mutations. More-
over, the two brothers with CISS reported with homozy-
gous frameshift deletions have an early-onset form of CISS
with neonatal manifestations (i.e., feeding difﬁculties and
difﬁculty opening mouth).6 These ﬁndings may suggest
that nonsense mutations are associated with the severe
neonatal manifestations of Crisponi syndrome, whereas
missense mutations are associated with late-onset CISS.
The ﬁnding of CRLF1 mutations in Crisponi syndrome
further illustrates the key role of the CNTFR pathway in
the function of the autonomous nervous system. Indeed,
Crisponi syndrome is mainly characterized by dysauto-
nomia symptoms—that is, disturbance in temperature
regulation; neonatal feeding, swallowing, and respiratory
difﬁculties; trismus and contractions of facial muscles;
camptodactyly; and paradoxical sweating. All these symp-
toms are also observed in SWS. By contrast, Crisponi
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Figure 4. Quantitative analysis of CRLF1 gene expression in ﬁ-
broblasts from patients 1, 3, and 4. The relative amounts of CRLF1
mRNA levels compared with b-actin mRNA levels were determined
for controls and for the three patients. The results shown are means
 SDs of two independent experiments. In each experiment, sam-
ples were run in triplicate.
syndrome is not characterized by congenital bowing of
the lower limbs, a characteristic feature of SWS. Hence,
dysautonomia symptoms observed in SWS would seem
to result from the impairment of the CNTFR pathway,
whereas the bone and cartilage manifestations character-
istic of SWS (and not observed in Crisponi syndrome)
would seem to be due to the speciﬁc impairment of the
LIFR pathway.
CRLF1 is a soluble cytokine receptor that associateswith
CLCF1 to form a soluble functional heteromeric ligand
and competes with CNTF for the binding to CNTFR.10
CNTF has an ability to maintain the survival of parasym-
pathetic neurons of chick ciliary ganglions, but mice lack-
ing CNTF appear remarkably normal, and CNTF homo-
zygous mutations have been identiﬁed in healthy hu-
mans.11 CRLF1-deﬁcient mice die shortly after birth be-
cause of a lack of suckling and also exhibit a signiﬁcant
reduction in facial and lumbar motor neurons.12 Similarly,
mice lacking CNTFR exhibit profound motor neuron def-
icits at birth and die perinatally.13 The identiﬁcation of
CRLF1 mutations in a severe congenital syndrome mainly
characterized by dysautonomic symptoms supports the
key role of the CNTFR pathway in the autonomic nervous
system function. We conclude that the proper binding of
CLCF1-CRLF1 to CNTFR is a major event for the auto-
nomic function and that impairment of this pathway is
associated with both Crisponi syndrome and CISS in
humans.
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